Coastlands Capital LP reports Adial Pharmaceuticals common share purchase worth $32,613.87
ADIL•Coastlands Capital increases Adial Pharmaceuticals stake
Coastlands Capital LP reports a common share purchase in Adial Pharmaceuticals worth $32,613.87.
- Coastlands Capital, a 10% owner of Adial Pharmaceuticals, increased its stake to 385,075 common shares.
- The purchases totaled 11,753 shares at prices ranging from $2.70 to $2.79.
